US 10391164
Vaccines for HSV-2
granted A61KA61K2039/545A61K2039/55572
Quick answer
US patent 10391164 (Vaccines for HSV-2) held by IMMUNE DESIGN CORP. expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- IMMUNE DESIGN CORP.
- Grant date
- Tue Aug 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K2039/545, A61K2039/55572, A61K38/00, A61K39/12